How do I identify digital health and telemedicine procurement trends?

Your competitor just won a £2M NHS digital health tender. You didn’t even know it was coming. How are they spotting opportunities you’re missing? 

This scenario plays out repeatedly across the digital health sector. Suppliers with strong telemedicine platforms and remote monitoring solutions are bidding reactively, discovering opportunities after tenders are published, and losing to competitors who seem to understand the market better. The problem isn’t their technology. It’s their intelligence. 

Telemedicine has become integral to UK healthcare, with over 20 million consultations conducted digitally last year. This shift has resulted in significant cost savings, with patients saving an average of £45 per consultation in travel and time costs. These cost savings benefit both healthcare systems and patients, making telemedicine an economically attractive option. Telemedicine also improves access to high-quality healthcare facilities, particularly for patients in rural areas, enhancing healthcare delivery across the country. Additionally, it allows patients to receive medical attention at the convenience of both doctor and patient, further improving overall healthcare access. 

Digital health procurement is fragmented. Opportunities scatter across multiple NHS frameworks, Integrated Care Board (ICB) portals, and regional buyer types. Without systematic trend-spotting, suppliers bid blind. They don’t know which buyers are investing. They don’t understand what commissioners prioritise. They can’t engage early, when relationships matter most. 

But here’s the opportunity: NHS digital health investment is accelerating. The Long Term Plan commits to digital-first primary care. The Elective Recovery Plan is driving virtual ward expansion. The Procurement Act 2023 has opened faster, more flexible procurement routes. The window to position early is now—but only if you know where to look. 

This guide teaches you how. You’ll learn where to find digital health procurement signals, how to interpret vendor landscapes and buyer priorities, which NHS frameworks matter most, and how to shift from reactive tender chasing to proactive market engagement. By the end, you’ll understand not just what’s coming—but how to position your solution before formal tenders are published. 

Defining digital health and telemedicine in the UK context 

Let’s start with clarity. Digital health encompasses a wide range of technology-enabled healthcare services and solutions, including telemedicine (remote consultations), remote patient monitoring, electronic health records (EHRs), digital therapeutics, and health information systems. In NHS procurement terms, it’s a broad category spanning software, devices, platforms, and integrated services, implemented by healthcare organisations to support and enhance the overall healthcare system. 

Telemedicine is the subset most visible right now. It includes video consultations, telephone triage, asynchronous messaging, and remote monitoring between patients and clinicians. Telemedicine services are increasingly integrated into the broader healthcare system, with healthcare professionals and medical practitioners playing a central role in delivering these services and ensuring patient safety and quality of care. But the NHS’s current focus is narrower: virtual wards – coordinated remote care for patients who would otherwise occupy hospital beds. From December 2025 HCI market data, over 111,000 people received care on a virtual ward in the 12 months leading to March 2025, with NHS England targeting 40-50 virtual ward beds per 100,000 population. 

The shift toward virtual wards is reshaping NHS procurement priorities. Buyers are no longer evaluating telemedicine as convenience (video consultations) but as clinical capacity, particularly Hospital at Home models for surgical, respiratory, and cardiac patients. This is critical: procurement specifications are evolving toward integration with Integrated Care Systems, remote monitoring at scale, and outcomes-focused evaluation. Adhering to good medical practice and regulatory standards is essential, with the regulatory framework overseen by bodies such as the General Medical Council (GMC) for individual medical practitioners and the Care Quality Commission (CQC) for telemedicine service providers. This evolution signals where digital health investment will concentrate in 2026 and beyond. 

Why does this matter? Because procurement trends reveal buyer investment patterns. When you understand where the NHS is investing, what commissioners prioritise (cost, clinical outcomes, integration, compliance), and which vendors are winning, you gain competitive advantage. You can identify high-growth market segments before they’re saturated. You can spot buyer priorities before they’re written into tender specifications. You can plan your product roadmap strategically. The regulatory framework for digital health is evolving not only in the UK but also in other countries, and suppliers should be aware of differences across countries to ensure compliance and successful implementation. 

Procurement trends emerge from five sources: policy signals (NHS England strategies, Long Term Plan priorities, Procurement Act 2023 reforms), funding cycles (annual budget announcements, digital transformation investment), technology maturity (new vendors entering, partnerships forming, consolidation happening), buyer behaviour (recurring tender patterns, framework cycles), and regulatory shifts. Suppliers who systematically monitor these signals gain early visibility, proactive engagement opportunities, and strategic positioning advantages. 

In summary, the GMC regulates individual medical practitioners in the UK, ensuring they are qualified to practice medicine, including in telemedicine. The CQC inspects telemedicine service providers to ensure they meet safety and quality standards. The Digital Technology Assessment Criteria (DTAC) outlines NHS-specific frameworks that digital health technologies must meet for successful market entry. Digital health apps classified as medical devices must comply with strict safety requirements, including pre-market conformity assessments and post-market surveillance to monitor safety and effectiveness. The UK government is also implementing new regulations to enhance the safety and effectiveness of medical devices, including digital health technologies, by 2026. 

How to spot procurement trends in the UK telemedicine market 

Identifying trends requires practical, systematic methods. The government and healthcare providers play a crucial role in shaping digital health procurement trends and policies, influencing both regulatory frameworks and the adoption of new technologies. Here are five evidence-based approaches: 

1. Monitor policy updates and strategy documents. NHS England publishes digital health strategies, investment plans, and technology roadmaps annually. Integrated Care Boards publish procurement plans and investment priorities. The Department of Health & Social Care publishes policy updates and legislative changes. Subscribe to NHS England news, follow ICB announcements, andmonitorGOV.UK for policy shifts. These documents signal where money is flowing 6–12 months before tenders appear. 
2. Track budget announcements and funding cycles. Annual NHS budget announcements reveal investment priorities. Specific funding streams-such as the NHS Digital Transformation Fund or Technology Refresh Programme – indicate where digital health spending will concentrate. Regional variations matter too. Some ICBs are ahead on digital maturity; others are catching up. Monitor budget announcements, track regional allocations, and identify growth areas. Funding and reimbursement for telehealth services, including NHS budgets and innovation grants, are critical for adoption; a lack of reimbursement policies can deter healthcare providers from implementing these solutions. 
3. Analyse recurring tender patterns. Which buyers tender repeatedly for digital health solutions?Identifyseasonal patterns (Q1/Q2 budget-driven tenders, Q4 framework renewals). Spot emerging categories (new telemedicine requirements, integrated care platforms). Review historical tenders from your target buyers and predict future opportunities based on cycle timing. 
4. Read between the lines of healthcare tender notices. Tender evaluation criteria reveal buyer priorities: cost, clinical outcomes, integration capability, compliance requirements. Specification details signal technical and regulatory expectations. Contract value and durationindicatemarket opportunity size. Incumbent supplier information (where available) reveals competitive threats. Analyse tender documents carefully and extract buyer priorities and competitive intelligence. 
5. Monitor vendor landscape changes. New vendors entering the market signal emerging opportunities. Vendor partnerships and integrations reveal buyer needs and ecosystem trends. Vendor consolidation and exits signal market maturity and competitive dynamics. Track vendor announcements,monitormarket entries and exits, and understand competitive positioning. 
6. Track Procurement Act 2023 pipeline notices. Under the Procurement Act 2023, authorities with annual spending over £5 million must publish forward pipelines (UK1, UK2, UK3 notices) covering 12–18 months ahead. FromHCImarket analysis conducted in February 2026, the health sector pipeline for 2026 shows 388 health frameworks expected with a combined value of £112 billion. Monitoring these pipeline notices gives you 12–18 months’ advance notice of procurement activity- a massive advantage over competitors who discover tenders reactively. Subscribe to pipeline notice alerts and cross-reference them against your target frameworks. This proactive approach transforms procurement from reactive discovery to strategic planning. 

Education and ongoing training for healthcare professionals are essential to ensure competence in digital health and telemedicine practices. Upskilling primary care doctors and providing adequate resources are significant challenges that must be addressed for effective implementation. Governments and healthcare organisations need to prioritise the development and implementation of telemedicine programmes, including comprehensive training, to ensure access to high-quality healthcare services. 

Data sources for digital health trend-spotting 

Where do you find these signals? Here are the essential sources: 

Policy and strategy documents: 

• NHS England digital health strategy and investment plans. 

• Integrated Care Board procurement plans (published annually in July). 

• Department of Health & Social Care policy updates and legislative guidance. 

Market intelligence platforms: HCI Contracts aggregates data from 90+ sources, providing award data (who won previous tenders and at what value), spend analysis (buyer spending patterns and category trends), market analytics (vendor landscape and competitive positioning), and tender alerts (automated notifications of new opportunities). This centralisation reduces manual research time significantly. 

Framework renewal cycles: The 2026 opportunity window. From HCI market analysis conducted in February 2026, nearly 7,000 frameworks are expiring in 2026 across all sectors, with the health sector alone accounting for 339 frameworks worth £70 billion in combined value. These frameworks – currently running under the Public Contracts Regulations 2015 – will be renewed under the Procurement Act 2023, with open, flexible procedures. For digital health suppliers, this creates a 12–month engagement window. Identify which health frameworks your solution fits (e.g., NHS Supply Chain, NHS SBS frameworks) and track their 2026 expiry dates. Begin early engagement 6–12 months before renewal to influence specifications and build buyer relationships. Framework renewals are highest-probability, highest-value opportunities for new suppliers entering the market. 

Industry news and publications: 

• Healthcare trade publications (Health Service Journal, Digital Health magazine). 

• Vendor announcements and press releases. 

• Industry conferences and webinars. 

Networking and early engagement: 

• Procurement officers and decision-makers at NHS trusts and ICBs. 

• Industry associations and procurement forums. 

• Vendor partnerships and ecosystem players. 

Centralising these sources manually is time-consuming and error-prone. Market intelligence platforms consolidate signals from all these sources, enabling faster trend-spotting and earlier buyer engagement. 

Navigating NHS digital procurement framework routes to market 

Understanding routes-to-market is critical. A route-to-market is the procurement pathway a buyer uses (framework agreement, open tender, direct award, etc.). Different routes have different eligibility criteria, timelines, and evaluation processes. Choosing the right route determines your competitiveness. 

Procurement frameworks for digital health often include medical services and dental care, requiring providers to comply with regulatory standards and oversight. For example, the Care Quality Commission (CQC) oversees telemedicine and digital health service providers in England, ensuring compliance with safety, quality, and legal criteria. 

Common NHS digital health frameworks: 

G-Cloud 14 (Crown Commercial Service): For cloud-based software and SaaS solutions (telehealth platforms, EHR systems, digital therapeutics). Fast-track procurement (30-day evaluation). Requires cloud hosting and SaaS model. Best for: Software vendors with rapid deployment capability. 

Technology Enabled Care Services 2 (TECS 2 – NHS SBS): For clinical and digital services (telemedicine service delivery, virtual ward platforms, digital health consulting). Longer timelines (60–90 days). Emphasises clinical safety, compliance, and service delivery capability. Best for: Service providers and integrated solution vendors. 

NHS Supply Chain: For medical devices and equipment (remote monitoring devices, telehealth hardware, medical peripherals). Competitive and lengthy (90–120 days). Emphasises cost competitiveness and clinical evidence. Best for: Device manufacturers with established clinical validation. 

Integrated Care Board (ICB) direct procurement: For innovative solutions or urgent needs. Fastest timelines (14–30 days) but limited scope. Best for: Pilot programmes and urgent digital health needs. 

The route-to-market shift under the Procurement Act 2023. The Procurement Act 2023 has fundamentally changed how NHS procurement works. From HCI market research conducted in February 2026, over 53,000 notices and awards have been published under the new Act within the first year, with 3,000 buyers now active on the new system. Key implication for digital health suppliers: direct awards for innovation (previously restricted) are now permitted, and competitive flexible procedures allow faster procurement cycles (14–30 days vs. the traditional 90–120 day tender). Additionally, frameworks are no longer closed for 3–5 years; they can reopen for new suppliers to apply. This means more routes to market, faster timelines, and more opportunities for suppliers who understand how to navigate the new procedures. Analyse each target buyer’s recent procurement history to identify which route they’re most likely to use for digital health: G-Cloud for SaaS, TECS 2 for services, or direct award for innovation pilots. 

Route selection depends on your solution type. Is it software, a service, a device, or an integrated offering? Identify which frameworks accept your category. Assess your readiness for each route (compliance certifications, clinical evidence, pricing structure). Prioritise frameworks with highest volume and fastest timelines for your solution type. 

Reading the vendor landscape: telehealth providers UK and telemedicine vendors 

The vendor landscape is a trend indicator. Vendor presence and positioning signal market maturity and buyer demand. Telemedicine providers and healthcare providers play a crucial role in transforming patient care within the NHS, with both NHS and private providers integrating to deliver a wide range of digital health services. Vendor partnerships reveal ecosystem trends and integration requirements, highlighting the benefits and significant impact of telemedicine—especially in rural areas—by improving access to specialist care and offering diverse treatment options. Telemedicine can enhance the quality of care provided to rural populations by connecting primary care doctors with specialists. Vendor consolidation signals market evolution. Vendor certifications signal buyer requirements. 

Interpreting vendor signals: 

• New vendors entering: Signal emerging opportunities and buyer demand. 

• Established vendors expanding: Signal market growth and increasing buyer adoption. 

• Vendor partnerships: Signal ecosystem maturity and integration requirements. 

• Vendor consolidation: Signal market maturity and competitive pressure. 

Vendor certifications and validations matter: 

• NHS Digital certification: Compliance with NHS standards. 

• CQC registration: Clinical safety and quality standards (if applicable). 

• MHRA approval: Regulatory compliance for medical devices. 

• ISO certifications: ISO 27001 (information security), ISO 13485 (medical devices). 

• Clinical evidence: Case studies, outcomes data, peer-reviewed publications. 

Competitive differentiation is essential. Analyse how competing vendors position themselves (cost vs. clinical outcomes vs. integration vs. compliance). Identify market gaps (underserved buyer needs, weak competitor positioning). Develop differentiation strategy based on these gaps. 

Buyers are increasingly sophisticated. Cost alone is insufficient. Differentiation on clinical outcomes, integration capability, compliance excellence, or innovation is critical. Early engagement and relationship-building strengthen positioning before formal tenders are published. 

Costs and budgeting: how much does telecare cost and what drives it? 

Understanding cost drivers helps you price competitively and position value. Telemedicine and digital health solutions offer significant cost savings by reducing travel and time costs for both patients and providers, as well as lowering the need for physical infrastructure. Remote treatment serves as an effective alternative to in-person care, supporting the healthcare system by increasing access and efficiency, especially for patients in remote areas. Remote prescribing of medicine and medications is a key feature, requiring strict compliance with regulatory standards to ensure patient safety and proper management. Telemedicine also streamlines follow up and follow up appointments, reducing the need for repeated in-person visits and improving workflow efficiency. Additionally, digital health platforms can help hospitals and clinics monitor discharged patients, manage recovery, and improve adherence to prescription care plans, which has been shown to reduce hospital readmissions. 

Cost components in digital health procurement include: 

• Licensing: Software licensing, per-user costs, annual subscriptions. 

• Devices: Remote monitoring devices, telehealth hardware, peripherals. 

• Connectivity: Broadband, mobile connectivity, network infrastructure. 

• Integration: System integration, API development, data migration. 

• Clinical safety: Regulatory approvals, clinical validation, governance. 

• Training: User training, clinical staff training, change management. 

• Support: Technical support, incident response, ongoing maintenance. 

Total Cost of Ownership (TCO) is increasingly important. Year 1 costs (licensing, devices, integration, training, initial support) differ significantly from Years 2–5 (ongoing licensing, support, upgrades, maintenance). Hidden costs (change management, staff time, infrastructure upgrades) often surprise buyers. Cost avoidance (reduced clinical staff time, reduced hospital admissions, improved efficiency) justifies investment. From December 2025 healthcare research, virtual ward beds cost nearly twice as much per day as hospital beds, yet they reduce overall length of stay and improve elective throughput—representing significant cost avoidance for commissioners evaluating telemedicine solutions. 

What drives cost variation? Scale (larger deployments have lower per-user costs), complexity (integrated solutions cost more than standalone platforms), compliance (regulatory approvals increase costs), and support model (managed services cost more than self-service). 

Buyers evaluate cost against clinical outcomes, compliance capability, and integration potential. Total cost of ownership models are increasingly standard. Value-for-money is critical—cost alone is insufficient. Develop tiered pricing models (basic, standard, premium). Emphasise TCO and value-for-money, not just upfront cost. Consider volume discounts for large deployments. 

Converting healthcare tender signals into a qualified pipeline 

Once you’ve identified trends, convert signals into qualified opportunities. Triage healthcare tender notices using four criteria: 

• Relevance: Does the tender match your solution and target market? 

• Fit: Do you meet eligibility criteria and requirements? 

• Value: Is contract value and duration worth the effort? 

• Timing: Do you have sufficient time to prepare a competitive bid? 

Score and prioritise using a framework: 

• Authority type: NHS trust, ICB, private provider (prioritise NHS trusts and ICBs). 

• Contract value: Higher value = higher priority (but consider effort required). 

• Stage: Early stage (framework renewal) = higher priority than late stage. 

• Contract length: Longer contracts = higher priority (multi-year revenue). 

• Competition: Lower competition = higher priority (higher win probability). 

Early engagement is critical. Contact the buyer, introduce your solution, express interest, request a meeting. Understand buyer challenges, requirements, and evaluation criteria. Propose improvements to procurement process or solution. Build relationships with procurement officers, clinical stakeholders, and budget holders. 

Build a qualified pipeline. Maintain CRM records of all tenders, scores, and engagement activities. Prioritise high-scoring opportunities for bid investment. Plan early engagement 6–12 months before tender publication. Track outcomes and learn from wins and losses. Identify framework renewal windows 6–12 months before expiry and plan early engagement during this period. 

Compliance and assurance: meeting NHS telemedicine requirements 

Compliance is not a cost—it’s a competitive advantage. Buyers increasingly prioritise compliance and risk de-risking. Early compliance demonstration strengthens bids. Compliance artifacts (certifications, audit reports, evidence) are critical bid components. 

There are growing concerns about data privacy, safety, and regulatory compliance in digital health, especially regarding telemedicine and digital health apps. Healthcare professionals must be trained to safeguard confidential patient information during telemedicine consultations and use secure platforms to protect data. Telemedicine training programs should incorporate evidence-based practices to enhance the quality of care provided remotely. 

Digital health apps classified as medical devices must comply with strict safety requirements, including pre-market conformity assessments and ongoing post-market surveillance to monitor their safety and effectiveness. The integration of machine learning in digital health apps and medical devices requires even more stringent oversight, with regulatory bodies ensuring these technologies meet safety, performance, and post-market surveillance requirements. 

Essential compliance requirements: 

Data protection and GDPR: GDPR compliance (lawful basis, consent, data minimisation), NHS Data Security and Protection Toolkit (DSPT) compliance, data processing agreements, patient consent mechanisms. 

Clinical safety: Clinical governance and risk management, incident reporting and learning (Serious Incident Framework), clinical validation and outcomes data, professional indemnity insurance. 

Information standards: FHIR-based APIs and open standards, NHS Interoperability Standards (SNOMED CT, HL7), integration with NHS systems (EHRs, patient records, scheduling). 

Regulatory compliance: MHRA approval (if applicable for medical devices), CQC registration (if applicable for service delivery), ISO certifications (ISO 27001 for information security, ISO 13485 for medical devices). 

Interoperability is increasingly non-negotiable. Interoperability is the ability of systems to exchange data and work together seamlessly. In NHS digital health, interoperability is critical to integration with EHRs, patient records, and scheduling systems. FHIR-based APIs enable secure, standardised data exchange. NHS increasingly requires FHIR compliance. Interoperability reduces implementation risk, enables faster adoption, and is increasingly a procurement requirement. 

Proving the importance of telemedicine: outcomes, ROI, and case signals 

Outcomes matter in NHS procurement. Buyers are increasingly outcomes-focused, not just cost-focused. Demonstrating clinical outcomes, cost avoidance, and efficiency gains strengthens bids. Outcomes data reveals buyer priorities and decision-making criteria. 

Telemedicine has a significant impact on patient care by enabling remote diagnosis and treatment, supporting the management of illness and chronic conditions. Through virtual consultation, healthcare professionals can offer a range of treatment options and treat patients who may not be able to attend in person, ensuring continuity of care. Remote monitoring technologies, including wearable devices and remote diagnostic tools, allow healthcare providers to track patient health data continuously, leading to better health outcomes. Artificial intelligence (AI) supports triage and diagnostics, ensuring urgent cases receive immediate attention and improving the accuracy of diagnosis and treatment plans. Telemedicine technologies also allow patients and doctors to review the treatment process together, enhancing the quality of care and patient engagement. Remote Patient Monitoring (RPM) with wearable devices and sensors enables proactive care management, while digital health applications help patients manage chronic conditions and improve adherence to treatment plans. Effective patient engagement through these technologies leads to improved health outcomes and satisfaction. 

Key outcome metrics for telemedicine: 

• Access: Reduced waiting times, increased appointment availability, improved access for remote patients. 

• Capacity: Increased clinical capacity, reduced hospital admissions, improved resource utilisation. 

• Cost avoidance: Reduced travel costs, reduced hospital admissions, reduced staff time. 

• Patient satisfaction: Improved patient experience, higher satisfaction scores, reduced complaints. 

• Clinical outcomes: Improved health outcomes, reduced readmissions, improved disease management. 

Collect and present evidence: Case studies (real-world implementation examples), testimonials (quotes from clinical staff and patients), outcome data (quantified metrics: “Reduced waiting times by 30%,” “Increased appointment capacity by 20%”), peer-reviewed publications (academic evidence of telemedicine effectiveness), ROI calculations (financial return on investment: “Payback period: 18 months”). 

Reveal buyer priorities from tender evaluation criteria. Different buyers prioritise different outcomes. Some focus on cost avoidance, others on clinical outcomes, others on access improvement. Tailor your evidence to match buyer priorities. Lead with outcomes that matter to the buyer, not just your strengths. Use quantified metrics and real-world examples. Connect outcomes to buyer challenges and priorities. 

How HCI helps you win digital health and telemedicine procurement 

Teams using procurement intelligence platforms identify digital health trends faster, qualify opportunities more accurately, and position bids more strategically. HCI centralise data from 90+ sources, automate alerts, and provide market insights that help suppliers move from reactive tender chasing to proactive market engagement. 

Strategy and market intelligence: Centralised access to digital health procurement data from 90+ sources. Trend analysis and market insights to guide strategic planning. Spend analysis to understand buyer priorities and budget allocation. Benefit: data-driven strategy instead of guesswork. 

Opportunity qualification: Automated tender alerts for digital health opportunities. Scoring and prioritisation tools to focus on high-value opportunities. Early engagement capabilities to contact buyers before formal tenders. Benefit: faster opportunity identification and higher-quality pipeline. 

Framework navigation: Centralised framework data (G-Cloud, NHS SBS, NHS Supply Chain, etc.). Framework expiry tracking and renewal planning. Route-to-market guidance for different solution types. Benefit: avoid framework lock-in and plan multi-year strategy. 

Bid management and compliance: Tender evaluation criteria analysis to understand buyer priorities. Compliance checklist and assurance tools. Competitive intelligence to inform bid positioning. Benefit: stronger bids and higher win rates. 

Pricing and TCO: Cost benchmarking against competitor pricing. TCO calculator and pricing model templates. Value-for-money positioning guidance. Benefit: defensible pricing and improved deal velocity. 

Get Further With Digital Health Procurement 

Digital health procurement trends are identifiable through systematic monitoring. Policy updates, funding cycles, tender patterns, and vendor landscape changes all signal where the NHS is investing and what commissioners prioritise. Suppliers who spot trends early gain competitive advantage through proactive engagement and strategic positioning. 

Use the trend-spotting methods in this guide: Monitor policy updates and strategy documents. Track budget announcements and funding cycles. Analyse recurring tender patterns. Read between the lines of healthcare tender notices. Monitor vendor landscape changes. Track Procurement Act 2023 pipeline notices for 12–18 months’ advance visibility. Identify framework renewal windows and plan early engagement. Prioritise frameworks with highest volume and fastest timelines for your solution type (G-Cloud for software, TECS 2 for services, NHS Supply Chain for devices). 

Digital health procurement is accelerating. The suppliers who win will be those who understand trends, engage buyers early, and position solutions strategically. Start trend-spotting today to position yourself for tomorrow’s opportunities. 

Ready to identify and win the right telemedicine opportunities? Explore how procurement intelligence can help you spot trends, qualify opportunities, and position your digital health solution strategically. Schedule a free demo with HCI today.